Filing Details

Accession Number:
0001493152-21-009781
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-26 18:16:46
Reporting Period:
2021-04-26
Accepted Time:
2021-04-26 18:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Qualigen Therapeutics Inc. QLGN Pharmaceutical Preparations (2834) 263474527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1822917 S. Amy Broidrick C/O Qualigen Therapeutics, Inc.,
2042 Corte Del Nogal
Carlsbad CA 92011
Evp, Chief Strategy Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-26 4,500 $2.03 4,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct